Idiosyncratic drug-induced neutropenia and agranulocytosis
暂无分享,去创建一个
E. Andrès | J. Gottenberg | B. Goichot | A. Korganow | J. Sibilia | R. Herbrecht | F. Maloisel | T. Vogel | G. Kaltenbach | O. Keller | J. Weber | F. Séverac | R. Mourot-Cottet | M. Tebacher
[1] G. Miremont-Salamé,et al. Imputabilité en pharmacovigilance : de la méthode française originelle aux méthodes réactualisées , 2016 .
[2] J. Palmblad,et al. How we diagnose neutropenia in the adult and elderly patient , 2014, Haematologica.
[3] E. Andrès,et al. Clinical presentation and management of drug-induced agranulocytosis , 2011, Expert review of hematology.
[4] F. Andersohn,et al. Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs , 2007, Annals of Internal Medicine.
[5] E. Andrès,et al. Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis. A study of 91 patients from a single center. , 2004, Presse medicale.
[6] A. Saleem,et al. Review: Drug-induced neutropenia--pathophysiology, clinical features, and management. , 2004, Annals of clinical and laboratory science.
[7] E. Andrès,et al. Life-Threatening Idiosyncratic Drug-Induced Agranulocytosis in Elderly Patients , 2004, Drugs & aging.
[8] E. Andrès,et al. Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. , 2002, European journal of internal medicine.
[9] E. Andrès,et al. Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor. , 2002, The American journal of medicine.
[10] F. Follath,et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. , 2000, British journal of clinical pharmacology.
[11] S. Shapiro,et al. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. , 1999, The American journal of tropical medicine and hygiene.
[12] M. Beauchesne,et al. Nonchemotherapy Drug‐Induced Agranulocytosis: A Review of 118 Patients Treated with Colony‐Stimulating Factors , 1999, Pharmacotherapy.
[13] B. Stricker,et al. A population-based case-cohort study of drug-associated agranulocytosis. , 1999, Archives of internal medicine.
[14] S. Fukata,et al. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. , 1999, Thyroid : official journal of the American Thyroid Association.
[15] M. M. van der Klauw,et al. Drug‐associated agranulocytosis: 20 years of reporting in The Netherlands (1974–1994) , 1998, American journal of hematology.
[16] E. Vellenga,et al. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. , 1994, Leukemia.
[17] S. Shapiro,et al. The drug etiology of agranulocytosis: An update of the international agranulocytosis and aplastic anemia study , 1993 .
[18] J. Bueno,et al. Drug‐induced agranulocytosis: prognostic factors in a series of 168 episodes , 1991, British journal of haematology.
[19] C. Bénichou,et al. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. , 1991, Nouvelle revue francaise d'hematologie.
[20] B. Chaimongkol,et al. Drug-induced agranulocytosis. , 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.